Clinical Trials Directory

Trials / Completed

CompletedNCT03690999

The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics

Impact of a Prebiotic Supplement on Microbiome, Immune System, and Metabolic Status of Older Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
98 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

An individual's immune and metabolic status is coupled to consumed carbohydrates. Complex carbohydrates that are not digested by human enzymes may influence host biology by impacting microbiota composition and function, or act in a yet-unknown microbiota-independent manner. Prebiotics offer a promising safe route to influence host health, possibly via the microbiota. However, it remains largely unknown to what extent immune function and metabolism can be modulated by prebiotics.

Detailed description

The objective of this study is to define the impact of a prebiotic supplement on microbiome, immune system, and metabolic status in older adults. This study will determine the degree to which a prebiotic supplement can 1) regulate immune status and function including reducing chronic, systemic inflammation as assessed by high dimensional immune profiling, 2) alter microbiota composition and function, 3) impact the microbiota metabolites-potential normalizers of metabolic and immune dysfunction, and 4) alter metabolic markers.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlaceboPlacebo product
DIETARY_SUPPLEMENTPrebiotic supplementPrebiotic supplement

Timeline

Start date
2019-03-14
Primary completion
2020-11-13
Completion
2020-12-14
First posted
2018-10-01
Last updated
2023-02-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03690999. Inclusion in this directory is not an endorsement.